Lymphohaematopoietic Growth Factors in Cancer Therapy (ESO Monographs)

Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the ESO Monographs series. The discussion revolves on the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research. Front Matter....Pages I-VII Introduction....Pages 1-1 Interleukins and Haematopoietic Growth Factors....Pages 3-17 Mechanisms of T-Cell Activation....Pages 19-23 Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals....Pages 25-35 Interleukin 2: In Vivo Induction of Effector Cells....Pages 37-46 Cellular Immunotherapy of Cancer: The use of Lymphokine-Activated Natural Killer (LANAK) Cells....Pages 47-56 Interleukin 2: Clinical Aspects....Pages 57-77 Interleukin 2 and LAK Cells....Pages 79-90 Back Matter....Pages 91-91